Investing Profile

Paul Da Silva Jardine

InvestorVC
Venture Partner at ATP
Photo of Paul Da Silva Jardine, Venture Partner at ATP (Apple Tree Partners)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
3
CompanyStageDateRound SizeTotal Raised
Red Queen Therapeutics
Series AAug 2024$55M
$55M
Co-investors: Joseph A. Yanchik III (ATP (Apple Tree Partners)), Seth L. Harrison (ATP (Apple Tree Partners)), Spiros Liras (ATP (Apple Tree Partners))
Deep Apple Therapeutics
Series ADec 2023$52M
$52M
Co-investors: Michael Ehlers (ATP (Apple Tree Partners)), Paul Eisenberg (ATP (Apple Tree Partners)), Seth L. Harrison (ATP (Apple Tree Partners)), Spiros Liras (ATP (Apple Tree Partners))
Aethon Therapeutics
Series AJan 2023$30M
$30M
Co-investors: Seth L. Harrison (ATP (Apple Tree Partners))